sábado, 10 de julio de 2021

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer | FDA

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer | FDA

No hay comentarios:

Publicar un comentario